BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11459450)

  • 1. Enhancement of gene expression by polyamidoamine dendrimer conjugates with alpha-, beta-, and gamma-cyclodextrins.
    Arima H; Kihara F; Hirayama F; Uekama K
    Bioconjug Chem; 2001; 12(4):476-84. PubMed ID: 11459450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with alpha-cyclodextrin.
    Kihara F; Arima H; Tsutsumi T; Hirayama F; Uekama K
    Bioconjug Chem; 2002; 13(6):1211-9. PubMed ID: 12440855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo gene transfer by an optimized alpha-cyclodextrin conjugate with polyamidoamine dendrimer.
    Kihara F; Arima H; Tsutsumi T; Hirayama F; Uekama K
    Bioconjug Chem; 2003; 14(2):342-50. PubMed ID: 12643744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sugar-appended polyamidoamine dendrimer conjugates with cyclodextrins as cell-specific non-viral vectors.
    Arima H; Motoyama K; Higashi T
    Adv Drug Deliv Rev; 2013 Aug; 65(9):1204-14. PubMed ID: 23602906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing effects of galactosylated dendrimer/alpha-cyclodextrin conjugates on gene transfer efficiency.
    Wada K; Arima H; Tsutsumi T; Hirayama F; Uekama K
    Biol Pharm Bull; 2005 Mar; 28(3):500-5. PubMed ID: 15744077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypseudorotaxanes of pegylated α-cyclodextrin/polyamidoamine dendrimer conjugate with cyclodextrins as a sustained release system for DNA.
    Motoyama K; Hayashida K; Higashi T; Arima H
    Bioorg Med Chem; 2012 Feb; 20(4):1425-33. PubMed ID: 22277591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible enhancing mechanisms for gene transfer activity of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate.
    Anno T; Higashi T; Motoyama K; Hirayama F; Uekama K; Arima H
    Int J Pharm; 2012 Apr; 426(1-2):239-247. PubMed ID: 22306427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of gene delivery mediated by mannosylated dendrimer/alpha-cyclodextrin conjugates.
    Wada K; Arima H; Tsutsumi T; Chihara Y; Hattori K; Hirayama F; Uekama K
    J Control Release; 2005 May; 104(2):397-413. PubMed ID: 15907588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of gene transfer activity mediated by mannosylated dendrimer/alpha-cyclodextrin conjugate (generation 3, G3).
    Arima H; Chihara Y; Arizono M; Yamashita S; Wada K; Hirayama F; Uekama K
    J Control Release; 2006 Nov; 116(1):64-74. PubMed ID: 17083992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polyfection as nonviral gene transfer method -design of novel nonviral vector using alpha-cyclodextrin].
    Arima H
    Yakugaku Zasshi; 2004 Jul; 124(7):451-64. PubMed ID: 15235229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a DNA carrier in vitro and in vivo.
    Anno T; Higashi T; Motoyama K; Hirayama F; Uekama K; Arima H
    J Drug Target; 2012 Apr; 20(3):272-80. PubMed ID: 22201459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential use of polypseudorotaxanes of pegylated polyamidoamine dendrimer with cyclodextrins as novel sustained release systems for DNA.
    Motoyama K; Hayashida K; Arima H
    Chem Pharm Bull (Tokyo); 2011; 59(4):476-9. PubMed ID: 21467677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA).
    Tsutsumi T; Hirayama F; Uekama K; Arima H
    J Control Release; 2007 Jun; 119(3):349-59. PubMed ID: 17477999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential use of folate-polyethylene glycol (PEG)-appended dendrimer (G3) conjugate with α-cyclodextrin as DNA carriers to tumor cells.
    Arima H; Arizono M; Higashi T; Yoshimatsu A; Ikeda H; Motoyama K; Hattori K; Takeuchi T; Hirayama F; Uekama K
    Cancer Gene Ther; 2012 May; 19(5):358-66. PubMed ID: 22402627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo gene delivery mediated by Lactosylated dendrimer/alpha-cyclodextrin conjugates (G2) into hepatocytes.
    Arima H; Yamashita S; Mori Y; Hayashi Y; Motoyama K; Hattori K; Takeuchi T; Jono H; Ando Y; Hirayama F; Uekama K
    J Control Release; 2010 Aug; 146(1):106-17. PubMed ID: 20678990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential use of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for short hairpin RNA-expressing plasmid DNA.
    Tsutsumi T; Hirayama F; Uekama K; Arima H
    J Pharm Sci; 2008 Aug; 97(8):3022-34. PubMed ID: 17932986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dendrimer/cyclodextrin conjugates as gene transfer carriers on nitric oxide production from macrophages.
    Motoyama K; Sako A; Ibrahim Abu Hashim I; Higashi T; Arima H
    J Pharm Pharmacol; 2016 May; 68(5):598-607. PubMed ID: 26076676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclodextrin/Dendrimer conjugates as DNA and oligonucleotide carriers.
    Arima H; Motoyama K; Higashi T
    Curr Top Med Chem; 2014; 14(4):465-77. PubMed ID: 24354672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of siRNA complexes with polyamidoamine dendrimer/α-cyclodextrin conjugate (generation 3, G3) on endogenous gene expression.
    Arima H; Tsutsumi T; Yoshimatsu A; Ikeda H; Motoyama K; Higashi T; Hirayama F; Uekama K
    Eur J Pharm Sci; 2011 Oct; 44(3):375-84. PubMed ID: 21896329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Findings Concerning PAMAM Dendrimer Conjugates with Cyclodextrins as Carriers of DNA and RNA.
    Arima H; Motoyama K
    Sensors (Basel); 2009; 9(8):6346-61. PubMed ID: 22454589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.